Cerenis Therapeutics' Series B Round

Cerenis Therapeutics raised a round of funding on November 17, 2006.

Cerenis Therapeutics is a biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases. Cereni…

Articles about Cerenis Therapeutics' Series B Round: